Showing results (181-190 of 745) with videos related to
Sort By:
Pageof 75
Journal of the American College of Nutrition|March 14, 2007
Flaxseed reduces plasma cholesterol levels in hypercholesterolemic mouse modelsMichael A Pellizzon, Jeffery T Billheimer, Leanne T Bloedon, et al.Lipids in Health and Disease|October 25, 2011
Changes in cholesterol homeostasis modify the response of F1B hamsters to dietary very long chain n-3 and n-6 polyunsaturated fatty acidsJaime L Lecker, Nirupa R Matthan, Jeffrey T Billheimer, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 18, 2014
Impaired cholesterol efflux capacity and vasculoprotective function of high-density lipoprotein in heart transplant recipientsNeha Singh, Frank Jacobs, Daniel J Rader, et al.Circulation Research|July 16, 2014
AAV vectors expressing LDLR gain-of-function variants demonstrate increased efficacy in mouse models of familial hypercholesterolemiaSuryanarayan Somanathan, Frank Jacobs, Qiang Wang, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|February 3, 2022
Web of Science's Citation Median Metrics Overcome the Major Constraints of the Journal Impact FactorAlan Daugherty, Robert A Hegele, Hong S Lu, et al.Clinical and Translational Science|August 20, 2010
Short-term treatment with high-dose atorvastatin reduces LDL cholesterol but shows no anti-inflammatory effects in normolipidemic subjects with normal CRP levelsJohn S Millar, Bonnie Ky, Megan L Wolfe, et al.Circulation Research|March 1, 2003
Endothelial cells secrete triglyceride lipase and phospholipase activities in response to cytokines as a result of endothelial lipaseWeijun Jin, Gwo-Shing Sun, Dawn Marchadier, et al.Circulation|August 4, 2004
Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosisMuredach P Reilly, Megan L Wolfe, Thomas Rhodes, et al.Pharmacotherapy|April 16, 2014
Pharmacokinetic interactions of the microsomal triglyceride transfer protein inhibitor, lomitapide, with drugs commonly used in the management of hypercholesterolemiaSony Tuteja, Danielle Duffy, Richard L Dunbar, et al.Atherosclerosis|April 18, 2013
Discordance between non-HDL-cholesterol and LDL-particle measurements: results from the Multi-Ethnic Study of AtherosclerosisEmil M Degoma, Mat D Davis, Richard L Dunbar, et al.Pageof 75